Does LORLATINIB Cause Off label use? 394 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 394 reports of Off label use have been filed in association with LORLATINIB (Lorbrena). This represents 7.2% of all adverse event reports for LORLATINIB.
394
Reports of Off label use with LORLATINIB
7.2%
of all LORLATINIB reports
97
Deaths
87
Hospitalizations
How Dangerous Is Off label use From LORLATINIB?
Of the 394 reports, 97 (24.6%) resulted in death, 87 (22.1%) required hospitalization, and 12 (3.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORLATINIB. However, 394 reports have been filed with the FAERS database.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
Peripheral swelling (164)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LORLATINIB Alternatives Have Lower Off label use Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE